Your Location：
Home >
Browse articles >
Regulation Effect and Clinical Efficacy of Addition and Subtraction Therapy of Jinkui Shenqiwan Combined with Buzhong Yiqitang on Immune Inflammatory Factors of Patients with Postmenopausal Osteoporosis and Deficiency of Spleen and Kidney
Clinic | Updated：2021-03-05
Previous|Next

    • Regulation Effect and Clinical Efficacy of Addition and Subtraction Therapy of Jinkui Shenqiwan Combined with Buzhong Yiqitang on Immune Inflammatory Factors of Patients with Postmenopausal Osteoporosis and Deficiency of Spleen and Kidney

    • AN Yu-lan , CAO Chang-xia , TIAN Yu-mei , REN Lei , LI Zhi-fang , CHENG Rong , LI Hai-ping , WU Tao , TANG Bao-ming
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 6, Pages: 69-75(2021)

    • DOI： 10.13422/j.cnki.syfjx.20202429     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 0 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

77

Views

103

Downloads

11

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Regulatory Effect of Guilu Bugu Prescription in Treating Th17/ Treg Cell Factors of Patients with Postmenopausal Osteoporosis Based on Syndrome Differentiation
Buzhong Yiqitang Combined with Cisplatin Inhibits Lung Adenocarcinoma Cell Proliferation by Suppressing PDK1/Akt Signaling Pathway and Regulating Glycolysis
Zuoguiwan Inhibit Bone Resorption in Ovariectomized Rats via STING/TBK1/NF-κB Signaling Pathway
Mechanism of Buzhong Yiqitang in Repairing Brain Developmental Abnormalities in Offspring of Pregnant Rats with Subclinical Hypothyroidism
Apoptosis Regulation by Buzhong Yiqitang via PERK/eIF2α/ATF4/CHOP Pathway to Enhance Pulmonary Surfactant-associated Protein C Expression and Ameliorate Lung Injury in CIH Mice

Related Author

Jin-yong LIU
He-ming WANG
Jian LIN
Xiu-ming CHEN
Yue-long FANG
Xiao-wen LIAN
Shu-he CAI
LI He

Related Institution

Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Fujian Key Laboratory of Rehabilitation Technology
School of Basic Medical Sciences， Liaoning University of Traditional Chinese Medicine（TCM）
General Hospital of Northern Theater Command
Teaching and Experimental Center，Liaoning University of TCM